Showing results (1331-1340 of 6,957) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|January 25, 2019
Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to HumanYin Cheong Wong, Maddalena Centanni, Elizabeth C M de LangeJournal of Clinical Pharmacology|December 20, 2018
Population Pharmacokinetics and Exposure-Response Analyses for CPX-351 in Patients With Hematologic MalignanciesQi Wang, Kamalika Banerjee, Grygoriy Vasilinin, et al.Journal of Clinical Pharmacology|December 20, 2018
Safety Exposure-Response Analysis for Daclatasvir, Asunaprevir, and Beclabuvir Combinations in HCV-Infected SubjectsMayu Osawa, Takayo Ueno, Tomomi Shiozaki, et al.Journal of Clinical Pharmacology|December 6, 2019
Population Pharmacokinetic Modeling of Acetaminophen Protein Adducts in Adults and ChildrenSibo Jiang, Kumpal Madrasi, Tanay Samant, et al.Journal of Clinical Pharmacology|December 11, 2019
Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome PatientsBrooks T McPhail, Chie Emoto, Tsuyoshi Fukuda, et al.Journal of Clinical Pharmacology|February 13, 2019
4β-Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical EvaluationScott R Penzak, Carlos Rojas-FernandezJournal of Clinical Pharmacology|November 12, 2020
Treatment With Tocilizumab for Patients With COVID-19 Infections: A Case-Series StudyYoonsun Mo, Obed Adarkwah, John Zeibeq, et al.Journal of Clinical Pharmacology|October 1, 1987
The bioavailability and pharmacokinetics of guanfacine after oral and intravenous administration to healthy volunteersS H Carchman, J T Crowe, G J WrightJournal of Clinical Pharmacology|October 1, 1987
Pharmacologic effects of A-49816, a new high-ceiling diureticR R Luther, G L Ringham, F J Steinberg, et al.Journal of Clinical Pharmacology|November 1, 1987
Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implicationsA M Katz, N M LeachPageof 696